Mycetia hekouensis, a new species is described and illustrated from Yunnan Province of China. The new species is akin to M. basiflora and M. mukerjiana in the basiflorous inflorescence, but morphologically differs by the relatively short, reddish peduncle, reddish calyx and white corolla. Morphological comparisons with closely related taxa are provided to delimit the new species, as well as photographic plates, field images, and a distribution map to visualize its morphology and range.

Amomi Fructus (SR) is an important edible herb widely used as a spice and traditional Chinese medicine. To comprehensively solve the serious practical problems of origins and species confusion in SR, the systematic characterization methods were established by liquid chromatography–mass spectrometer, gas chromatography–mass spectrometer, nuclear magnetic resonance and infrared spectroscopy. A total of 286 compounds and functional group information were detected. The classification of SR from different origins was performed by data fusion models built using random forest (RF) and other algorithms. A mid‐level data fusion model (an RF model established after combining the features selected by RF and RF–RF) performed the best classification. Then 27 differential compounds (including flavonoids, polyphenols and terpenoids) and their functional group information were screened for external verification and could significantly improve the groups’ separation effect just by simple principal component analysis. A more comprehensive and accurate means of analysis was found.

Kadsura Kaempf. ex Juss., belonging to the Schisandraceae family, is a key ethnomedicinal resource in traditional Asian medicine, valued for both dietary and therapeutic roles. Traditionally used to boost blood circulation, relieve pain, and dispel wind-cold-damp pathogens, its metabolites have been validated by modern pharmacology to exhibit potent anti-rheumatoid arthritis, hepatoprotective, antioxidant, and anti-inflammatory properties, supporting clinical applications for rheumatic and hepatic conditions. Literature was retrieved from major databases (Google Scholar, Web of Science, PubMed, ScienceDirect, Baidu Scholar, CNKI, etc.), monographs, and dissertations using “ Kadsura ” as the core keyword. Species identities were verified via Plants of the World Online ( http://www.plantsoftheworldonline.org ), and data on ethnobotany, pharmacology, and molecular pharmacognosy were rigorously screened and synthesized. Our analysis reveals that while Kadsura species share core medicinal attributes, the scientific basis for their species-specific traditional therapeutic effects remains unclear. Furthermore, the mechanisms of some pharmacological activities are not fully elucidated, systematic safety evaluations are insufficient, and molecular pharmacognosy research is limited to preliminary transcriptomic and metabolomic screening and expression profiling. Meanwhile, systematic reviews on these aspects remain lacking. To address this gap, this review summarizes the ethnobotany, pharmacology, and molecular pharmacognosy of the genus to date, laying a theoretical foundation for further development and utilization ( Kadsura ananosma Kerr, a synonym of Kadsura coccinea (Lem.) A.C.Sm.; Kadsura polysperma Y.C.Yang and Kadsura interior A.C.Sm., a synonym of Kadsura heteroclita (Roxb.) Craib).